Drug recall · February 14, 2024
Phenoxybenzamine Hydrochloride Capsules recall
Why: Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01
- Lots / codes
Lot # AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025
- Quantity
- 858 bottles
- Company
- Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY
- Distribution
- USA nationwide.
- Initiated
- January 15, 2024 · Voluntary: Firm initiated
- Classified
- February 8, 2024
- Reported
- February 14, 2024
- Ended
- January 31, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenoxybenzamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.